Skip to content

Clinical trials

Lung Diseases, Interstitial trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: France Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20082
20091
20122
20132
20141
20161
20175
20182
20195
20209
20213
202211
202310
20248
20258
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting22
Active, not recruiting9
Unknown status9
Not yet recruiting7
Terminated5
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim10
Assistance Publique - Hôpitaux de Paris8
Hospices Civils de Lyon6
Central Hospital, Nancy, France4
University Hospital, Tours4
Bristol-Myers Squibb3
GlaxoSmithKline3
United Therapeutics3
ADIR Association2
Centre Hospitalier Universitaire de Nice2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial83
Idiopathic Pulmonary Fibrosis12
Pulmonary Fibrosis12
Scleroderma, Systemic10
Arthritis, Rheumatoid7
Scleroderma, Diffuse7
Connective Tissue Diseases6
Idiopathic Interstitial Pneumonias5
Hypertension, Pulmonary4
Lung Diseases4

Trials

Showing 76 to 83 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.